Go Pro
Your confirmation email is on its way. Please check your inbox for further instructions.

Rocket Lab (NASDAQ:RKLB) Insider Sells 35,558 Shares of Stock

Rocket Lab logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Rocket Lab insider Frank Klein sold 35,558 shares for approximately $2.37 million under a pre-arranged Rule 10b5-1 plan, reducing his stake by 3.7% to 925,737 shares. He also sold 45,692 shares earlier in the week.
  • RKLB shares fell 4.6% to $64.39, well below their 50-day and 200-day moving averages. The company remains unprofitable after reporting an $0.08 quarterly loss per share, though revenue exceeded expectations.
  • Analysts maintain a broadly positive outlook, with a “Moderate Buy” consensus and an average price target of $110.65. Institutional investors own 71.78% of the stock, while defense and space-systems demand provide potential growth support.
  • Interested in Rocket Lab? Here are five stocks we like better.

Rocket Lab Corporation (NASDAQ:RKLB - Get Free Report) insider Frank Klein sold 35,558 shares of Rocket Lab stock in a transaction dated Thursday, August 27th. The stock was sold at an average price of $66.61, for a total value of $2,368,518.38. Following the completion of the transaction, the insider owned 925,737 shares in the company, valued at approximately $61,663,341.57. This represents a 3.70% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Frank Klein also recently made the following trade(s):

  • On Monday, August 24th, Frank Klein sold 45,692 shares of Rocket Lab stock. The shares were sold at an average price of $69.63, for a total value of $3,181,533.96.

Rocket Lab Trading Down 4.6%

RKLB stock traded down $3.14 during trading on Friday, hitting $64.39. 18,486,456 shares of the company traded hands, compared to its average volume of 23,476,473. The company has a 50-day moving average of $78.66 and a 200-day moving average of $85.12. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.98 and a current ratio of 5.48. Rocket Lab Corporation has a 1 year low of $37.57 and a 1 year high of $151.00. The firm has a market capitalization of $38.53 billion, a PE ratio of -238.47 and a beta of 2.60.

Rocket Lab (NASDAQ:RKLB - Get Free Report) last announced its quarterly earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) EPS for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.02). The company had revenue of $234.07 million during the quarter, compared to analysts' expectations of $231.62 million. Rocket Lab had a negative return on equity of 6.48% and a negative net margin of 21.51%. Analysts predict that Rocket Lab Corporation will post -0.2 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Rocket Lab

Large investors have recently modified their holdings of the stock. Corient Private Wealth LP raised its stake in Rocket Lab by 795.2% in the second quarter. Corient Private Wealth LP now owns 476,241 shares of the rocket manufacturer's stock worth $48,410,000 after buying an additional 423,039 shares in the last quarter. Amundi boosted its position in Rocket Lab by 22.2% during the 2nd quarter. Amundi now owns 2,180,748 shares of the rocket manufacturer's stock valued at $221,673,000 after acquiring an additional 396,639 shares in the last quarter. HighTower Advisors LLC grew its holdings in shares of Rocket Lab by 4.2% during the 2nd quarter. HighTower Advisors LLC now owns 109,226 shares of the rocket manufacturer's stock worth $11,103,000 after acquiring an additional 4,407 shares during the period. Groupe la Francaise purchased a new position in shares of Rocket Lab during the 2nd quarter worth approximately $725,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in shares of Rocket Lab in the 2nd quarter worth approximately $1,071,000. Institutional investors own 71.78% of the company's stock.

Wall Street Analyst Weigh In

RKLB has been the subject of several analyst reports. Morgan Stanley reissued an "overweight" rating on shares of Rocket Lab in a research report on Wednesday, July 8th. KGI Securities raised shares of Rocket Lab from a "neutral" rating to an "outperform" rating and set a $107.00 price objective for the company in a research note on Monday, July 27th. Stifel Nicolaus set a $132.00 target price on Rocket Lab in a research note on Thursday, June 4th. Craig Hallum boosted their price target on Rocket Lab from $98.00 to $120.00 and gave the company a "buy" rating in a report on Monday, June 29th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on Rocket Lab from $73.00 to $120.00 and gave the stock a "buy" rating in a report on Tuesday, May 12th. Three equities research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $110.65.

View Our Latest Report on RKLB

Key Rocket Lab News

Here are the key news stories impacting Rocket Lab this week:

  • Positive Sentiment: Defense and space-systems demand remain important growth drivers. Rocket Lab is benefiting from its selection by Viasat to build spacecraft buses for the U.S. Space Force’s Protected Tactical SATCOM-Global program. Its HASTE hypersonic test platform is also expanding the company’s exposure to Pentagon missions, supporting the view that Rocket Lab is more than an Electron launch provider. Rocket Lab HASTE defense coverage
  • Positive Sentiment: Electron execution and analyst revisions offer potential support. Rocket Lab has reached 93 Electron launches, while some analysts have raised earnings estimates. A hammer chart pattern has also prompted bottom-fishing interest after the decline. Rocket Lab bottom-fisher coverage
  • Neutral Sentiment: Analysts remain broadly bullish, but the valuation requires strong execution. Rocket Lab carries a reported “Moderate Buy” consensus and an average price target of $110.65, but the company remains unprofitable and trades at a high valuation relative to current earnings. Its elevated beta also leaves the stock vulnerable to sharp swings.
  • Negative Sentiment: Neutron timing is the largest operational risk. Reports that the medium-lift Neutron rocket’s first launch could slip into 2027 have weakened a key investment thesis. The delay would postpone a major revenue and valuation catalyst while extending development costs. Rocket Lab Neutron timeline coverage
  • Negative Sentiment: Insider selling adds to near-term pressure. Five executives sold approximately $5.5 million of shares, including sizable sales by the CFO and COO. The transactions were made under Rule 10b5-1 plans to cover tax withholding on vested restricted stock units, reducing their significance, though no comparable insider buying was reported. Rocket Lab executive sale coverage
  • Negative Sentiment: Profitability remains a concern. Rocket Lab’s latest quarterly revenue exceeded expectations, but its $0.08-per-share loss was wider than forecast. Continued annual losses make the stock particularly sensitive to acquisition uncertainty, Neutron delays, and any slowdown in launch or defense growth.

About Rocket Lab

(Get Free Report)

Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company's primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company's propulsion capabilities.

Recommended Stories

Insider Buying and Selling by Quarter for Rocket Lab (NASDAQ:RKLB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Rocket Lab Right Now?

Before you consider Rocket Lab, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rocket Lab wasn't on the list.

While Rocket Lab currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines